Literature DB >> 1542664

Peptide mimetics of the thrombin-bound structure of fibrinopeptide A.

H Nakanishi1, R A Chrusciel, R Shen, S Bertenshaw, M E Johnson, T J Rydel, A Tulinsky, M Kahn.   

Abstract

Recent work has suggested that the thrombin-bound conformation of fibrinopeptide A exhibits a strand-turn-strand motif, with a beta-turn centered at residues Glu-11 and Gly-12. Our molecular modeling analysis indicates that the published fibrinopeptide conformation cannot bind reasonably to thrombin but that reorientation of two residues by alignment with bovine pancreatic trypsin inhibitor provides a good fit within the deep thrombin cleft and satisfies all of the experimental nuclear Overhauser effect data. Based on this analysis, we have successfully designed and synthesized hybrid peptide mimetic substrates and inhibitors that mimic the proposed beta-turn structure. The results indicate that the turn conformation is an important aspect of thrombin specificity and that our turn mimetic design successfully mimics the thrombin-bound conformation of fibrinopeptide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1542664      PMCID: PMC48521          DOI: 10.1073/pnas.89.5.1705

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  11 in total

1.  Prohormonal cleavage sites are associated with omega loops.

Authors:  E Bek; R Berry
Journal:  Biochemistry       Date:  1990-01-09       Impact factor: 3.162

2.  Chemical basis of thrombin interactions with fibrinogen.

Authors:  H A Scheraga
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

3.  Leaving group specificity in the chymotrypsin-catalyzed hydrolysis of peptides. A stereochemical interpretation.

Authors:  A R Fersht; D M Blow; J Fastrez
Journal:  Biochemistry       Date:  1973-05-22       Impact factor: 3.162

4.  Precursors for peptide hormones share common secondary structures forming features at the proteolytic processing sites.

Authors:  M Rholam; P Nicolas; P Cohen
Journal:  FEBS Lett       Date:  1986-10-20       Impact factor: 4.124

5.  D-Phe-Pro-ArgCH2C1-A selective affinity label for thrombin.

Authors:  C Kettner; E Shaw
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

6.  Covalent structure of fibrinogen.

Authors:  A Henschen; F Lottspeich; M Kehl; C Southan
Journal:  Ann N Y Acad Sci       Date:  1983-06-27       Impact factor: 5.691

7.  Evidence for beta-turn structure in model peptides reproducing pro-ocytocin/neurophysin proteolytic processing site.

Authors:  M Rholam; P Cohen; N Brakch; L Paolillo; A Scatturin; C Di Bello
Journal:  Biochem Biophys Res Commun       Date:  1990-05-16       Impact factor: 3.575

8.  Mechanism of action of thrombin on fibrinogen. Kinetic evidence for involvement of aspartic acid at position P10.

Authors:  H C Marsh; Y C Meinwald; T W Thannhauser; H A Scheraga
Journal:  Biochemistry       Date:  1983-08-30       Impact factor: 3.162

9.  The structure of a complex of recombinant hirudin and human alpha-thrombin.

Authors:  T J Rydel; K G Ravichandran; A Tulinsky; W Bode; R Huber; C Roitsch; J W Fenton
Journal:  Science       Date:  1990-07-20       Impact factor: 47.728

10.  The refined 1.9 A crystal structure of human alpha-thrombin: interaction with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-Trp insertion segment.

Authors:  W Bode; I Mayr; U Baumann; R Huber; S R Stone; J Hofsteenge
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

View more
  2 in total

1.  Hirunorms are true hirudin mimetics. The crystal structure of human alpha-thrombin-hirunorm V complex.

Authors:  G De Simone; A Lombardi; S Galdiero; F Nastri; R Della Morte; N Staiano; C Pedone; M Bolognesi; V Pavone
Journal:  Protein Sci       Date:  1998-02       Impact factor: 6.725

2.  Metal complexes of chiral pentaazacrowns as conformational templates for beta-turn recognition.

Authors:  Andrea J H Reaka; Chris M W Ho; Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2002 Aug-Sep       Impact factor: 3.686

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.